摘要
本实验以氟中毒大鼠动物模型和体外成骨细胞染氟培养为研究对象,应用形态学、免疫组织(细胞)化学、原位杂交、Western blot和ELISA等技术,着重对氟化物作用时OCN、OPN、FN、ON及与其密切相关的TGF-β从mRNA到蛋白质的表达进行了探讨。结果表明,在氟中毒大鼠骨组织OCN、OPN、FN、ON等四种非胶原蛋白和TGF-β的表达在投氟组与对照组之间未发现明显差别。在体外培养成骨细胞,染氟1,2,4mg/L,培养48,72h,可在mRNA到蛋白质水平显著促进这四种非胶原蛋白和TGF-β的表达。氟作用下这些非胶原蛋白的合成和分泌增多,很可能在进一步促进成骨细胞增殖、活化和调节矿化等方面发挥作用。本研究为全面了解氟骨症的发生机制提供了有价值的新资料。
The bone damage of chronological fluorosis relates to multi-cells and extracellular matrix, which participate in bone transition.Non-collagenous proteins,as the important ingredient of extracellular matrix,play an important role in the osteogenesis and bone transition.But the systematical and further research on the influence of related fluorides to non-collagenous bone matrix proteins and the function of proteins of transformation of bone matrix to the development of fluorosis of bone,were rarely done.Via fluoride concentration in drinking water to replicate casts of white-rat fluorosis and culture in vitro osteoblast fluoridized,and adopting the technology of morphology, immunohistochemistry,in situ hybridization,RT-PCR,Western blot and ELISA,this experiment mainly carried out the research on the influence of fluoride to the following non-collagenous proteins,such as osteocalcin,osteopontin,osteonetin,as well as the expression of transforming growth factorβwhich closely relates to them.
By observing the bone tissue casts of fluorotic rats, bony trobecula of metaphysis crowded together;osteoblast and osteoclast increase tremendously,and
引文
1. 何志谦. 均衡营养—现代生活中的一个战略概念.见:中国膳食指南专 家委员会主编,《中国居民膳食指南》文集. 北京:中国检察出版社. 1999, 59-78.
2. 陈秉衡,曲卫东.世界卫生组织对氟化物的卫生评价.中国地方病学杂 志,2000,19(6):477-478.
3. 刘明俊.氟化物及有机氟农药中毒.见:郭景元主编.实用法医学.第1 版.上海:上海科技出版社,1980,261-263.
4. Grandjean P.Occupational fluorosis through 50 years:Clinical and epidermiological experience.Am J Industrial Med,1982,3: 227-236.
5.Frank J. A new concept of the effect of fluoride on bone.Fluoride, 1979,12(4):195-208.
6. 李广生,刘晓秋.慢性氟中毒的骨相损害.见:李广生,主编.地方性氟 中毒发病机制.第1 版.北京:科技出版社;2004:20-31.
7. Faccini JM. Inhibition of bone resorption in the rabbit by fluoride.Nature,1967,214: 1269-1271.
8. Bely M.Experimental fluorosis in rats: NaF input, changes of bone and bone marrow.Fluoride,1983,16(2):106-111.
9. Bely M.The inhibite denchondral ossification in experimental osteofluorosis in rats.Fluoride,1991,24(1):17-22.
10. Bely M, Ferencz G, Itai K,et al.Experimental osteofluorosis and arthrofluorosis in rats.Fluoride,1997,30(2):113-114.
11. 李广生,杨同书,井玲等.过量氟对软骨的损害.中国地方病防治杂志,1991,6:196-198.
12. Higashijima S,Nose A,Eguchi et al.Mindin/F-spondin family:novel ECM proteins expressed in the zebrafish embryonic axis. Dev Biol,1997,12:211-227.
13. Mutsaers SE, Bishop JE, McGrouther G et al.Mechanisms of tissue repair:from wound healing to fibrosis.Int J Biochem Cell Biol,1997,29:5-17.
14. Gomez DE,Alonso DF,Yoshiji H,et al.Tissue inhibitors of metalloproteinases : structure , regulation and biological functions.Eur J Cell Biol,1997,74:111-122.
15. Roach H.Why does bone matrix contain non-collageous proteins?The possible roles of osteocalcin ,osteteonectin,osteopontin and bone sialoprotein in bone mineralisation and resorption.Cell Biol Int,1994,18:617-628.
16. Amizuka N. Bone quality in the respect of bone matrix.Clin Calcium,2004,14(4):589-593.
17. Marom R, Shur I, Solomon R, et al. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol,2005,202(1):41-48.
18. 张伟国,王丽珍,刘正.氟对鼠颅骨成骨细胞基质蛋白表达的影响.上海口腔医学,1998,7(2):94-98.
19. Kohlmeier M,Salomon A,Saupe J,et al.Transport of vitamin K to bone in humans.J Nutr,1996,126:1192-1196.
20. 张会丰,李伟.机体维生素 K 营养状况评价指标的研究进展.国外医学卫生分册,2001,28(5):292-294.
21. Schoau E,Rauch F.Markers bone and collagen metabolism problems and perspectives in pediatrics.Horm Res,1997,48(5):50-59.
22. 刘树人.肝细胞胶原合成及其I 型胶原mRNA 的稳定性.胃肠病学及肝病学杂志,1998,7(4):335-338 .
23. Lian J,Steuart C,Puchacz E,et al.Proc Natl Acad Sci USA,1989,86(25):1143-1147.
24. 王华,黎海芪.骨钙素基因表达及转录调控的分子机制.国外医学儿科分册,1998,25(2):60-64.
25. Tenori D,Foyle DM,Hughes FJ.The modulatory role of cementam matrix on osteoblastic cells in vitro. J Periodontal Res,1997,32(4):362-374.
26. Owen TA,Bortell R,Yocum SA,et al.Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene:model for phenotype suppression of transcription.Proc Natl Acad Sci USA,1990,87(24):9990-9994.
27. Hoshi K,Nomura K,Sano Y,et al.Nuclear vitamin K2 binding protein in human osteoblasts:homologue to glyceraldehyde-3-phosphate dehydrogenase.Biochem Pharmacol,1999,58:1631-1638.
28. Cracium J,Wolf H,Knapen HJ,et al.Improved lone metabolism in female elite Athletes after vitamin K Supplementation.Int J Sport Med,1998,19:479-484.
29. Virtanen P,Vitasalo J,Vuori J,et al.Effect of concentric exercise on serum muscle and collagen markers.J Appl Physiol,1993,75(3):1272-1277.
30. Kritoffersson A,Hutdin J,Holmlund L,et al.Effect of shortterm maximal work on plasma calcium,parathyroid hormone,osteocalcin and biochemical markers of collagen metabolism.Int J Sport Med,1995,16(3):145-149.
31. 刘兰芬,候连云.孕妇口服维生素 K 对新生儿体内含量水平的影响,山西临床医药杂志,1999,8(6):410-412.
32. Sokoll LJ,O Brien ME,Camilo ME,et al.Undercarboxylatedosteocalcin and development of a method to determine vitamin K status.Clin Chem,1995,41:11-21.
33. 许豪文,周红律.骨质疏松、维生素 K 和运动.天津体育学院学报,2003,18(2):51-53.
34. Romberg RW, Werness PG, Riggs BL, etal. Inhibition of hydroxyapatite cryatal growing by bone specific and other calcium binding proteins.Biochemistry,1986,25:1176-1180.
35. 柴岗,张艳,王敏等.人骨髓基质细胞诱导成骨细胞和脱钙骨粘附率的研究.实用美容整形外科杂志,2003,14(2):66-69.
36. 呼莹,马丽,马冠杰,等.成人和胎儿骨髓间充质干细胞的研究.中华血液学杂志,2002,23(12):645-648.
37. 潘红芽.骨肉瘤基因治疗的研究进展.中国肿瘤,2002,11(8):459-461.
38. 李江,何荣根.非胶原蛋白在颌面部骨肉瘤病理诊断中的价值.诊断病理学杂志,2001,8(3):143-145.
39. 褚为靖.甲状腺功能异常的女性血中骨钙蛋白、甲状旁腺素和降钙素水平的变化.中国内分泌代谢杂志,1996,12(4):250-251.
40. 盛春永,张琴,王春兰等.骨钙素 RIA 在甲骨病中的作用.放射免疫学杂志,1994,7(4):238-239.
41. 李健.慢性肾功能衰竭和肾移植患者血清骨钙蛋白测定及意义.西安医科大学学报,1996,17(3):353-355.
42. Denhardt DT,Guo XJ.Osteopontin:a protein with diverse functions.FASEB,1993,7(12):1475-1482.
43. Sodek J,Chen J,Nagata T,et al.Regulation of osteopnontin expression in osteoblasts.Ann-N-Y-Acad-Sci,1995,21,760:223-241
44. 刘宏,王勤涛,吴织芬等.rhBMP-2 对人牙牙周细胞骨桥蛋白表达的影响.中华口腔医学杂志,2000,35(5):330-331.
45.Takahashi K,Takahashi F,Tanabe KK,et al.The carboxylterminal fragment of osteopontin suppresses arginine-glycine-asparatic acid-dependent cell adhesion.Biochem Mol Biol Int,1998,46(6):1081-1092.
46. 杨淑莉,韩梅,温进坤.骨桥蛋白与心血管疾病.中国动脉硬化杂志,2000,8(4):371-373.
47. 杨恬,向明明.大鼠皮肤及毛囊骨桥蛋白研究.中国医学院学报,2000,22(3):296-299.
48. Reinholt FP,Hultenby K,Oldberg A,et al.Osteopontin-a possible anchor of osteoclasts to bone.Proc Natl Acad Sci USA,1990,87(12):4473-4475.
49. Mark MP,Prince CW,Oosawa T,et al.Inmunohistochemical demonstration of a 44-kD phosphoprotein in developing rat bones.Histochem Cytochem,1987,35(7):707-715.
50. 王立平,党耕町. 骨桥蛋白在骨愈合中的基因表达. 北京医科大学学报,1998,30(4):355-357.
51. Owen TA,Aronow M,Shalhoub V,et al. Progressive development of the osteoblast type in vitro:Reciprocal relationships in expression of genes associated osteoblast priliferation and differentiation during formation of the bone extracellular matrix.Cell Physiol,1990,143(3):420-430 .
52. Oldberg A,Franzen A,Heinegard D.Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Aspcell-binding sequence.Prog Natl Acad Sci USA, 1986,83:8819-8823.
53. Somerman MJ,Prince CW,Sauk JJ,et al.Mechanism of fibroblast attachment to bone extracellular matrix:role of a 44 kilodeltonbone phosphoprotein.Bone Miner Res,1987,2(3):259-265.
54. Hunter GK,Goldberg HA.Modulation of crystal formation by bone phosphoproteins:role of glutamic acidrich sequences In the nucleation of hydroxyapatite by bone sialoprotein.Biochem,1994,302(Pt 1):175-179.
55. 张红军.骨桥蛋白的功能及与消化系统等疾病的关系.《国外医学》生理病理及临床分册,1999,19(6):524-527.
56. 高建军.破骨细胞成熟和活化以及骨吸收机制.《国外医学》内分泌分册,1998,18(2):57-61.
57. 刘大为,傅民魁,李盛琳等.机械牵张作用对细胞骨桥蛋白和表达的影响.中国口腔医学杂志,2000;35(1) : 27-30.
58. Jin C,Miyaura C,Ishimi I,etal.Interleukin 1 regulates the expression of osteopontin mRNA by osteoblast . Mol Cell Endocrinol,1990,74:221-228.
59. Terai K,Takano Yamamoto T,Ohba Y,etal.Role of osteopontin in bone remodeling caused by mechanical stress.J Bone Miner Res,1999,14:839-849.
60. 许丽辉,韩梅,温进坤,基质金属蛋白酶-2 和骨桥蛋白基因在动脉粥样硬汉组织中的表达.中国老年学杂志,2001,21:41-42.
61. 周秀霞,温进坤,韩梅.白细胞介素-1β和肿瘤坏死因子-α对血管平滑肌细胞及基质金属蛋白酶-2 骨桥蛋白基因表达的影响.中国动脉硬化杂志,1999,7(4):292-295.
62. 孙爱军.骨桥蛋白在血管重塑中的作用.《国外医学》生理、病理科学与临床分册,2001,21(6):474-475.
63. 石缨,温进坤. 新生小牛血清、碱性成纤维细胞生长因子和肝素对大鼠血管平滑肌细胞骨桥蛋白基因表达的影响.中国动脉硬化杂志,1999,7:1-3.
64. Wang X,Louden C,Ohlstein EH,et al.Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after ballon angioplasty.Arterioscler Thromb Vasc Biol,1996,16(11):1365-372.
65. Panda D,Kundu GC,Lee BI,et al.Potential role of osteopontin and alphavbeta3 integrin in the development of coronary artery restenosis after angioplasty.Proc Natl Acad Sci USA,1997,94(17):9308-313.
66. Demer LL, Titut Y.Osteopontin between a rock and a hard plaque.Girc Res,1999,84:250-252.
67. 贺斌,刘银坤,汤钊猷,等.肝癌中骨桥蛋白表达的临床意义.中华肝脏病杂志,1998,6(4):208-210.
68. Yamamoto M,Aoyagi M,Azuma H,et al.Changes in osteopontin mRNA expression during phenotypic transition of rabbit arteral smooth muscle cells.Histochem Cell Biol,1997,107:279-287.
69. Tuck AB,O'Malley FP,Singhal H,et al.Osteopontin and p53 expression are associated with tumor progression in a case of synchronous,bilateral,invasive mammary carcinomas.Arch Pathol Lab Med,1997,121(6):578-584.
70. 李江,何荣根.非胶原蛋白在颌面部骨肉瘤病理诊断中的价值.诊断病理学杂志,2001,8(3):143-145.
71. Ue T,Yokozaki H,Kitadai Y,et al.Co-expression of osteopontin and CD44v9 in gastric cancer.Int Cancer,1998:127-132.
72. Casson AG,Wilson SM,McCart JA,et al.Ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer.Int Cancer,1997,72(2):739-745.
73. Saitoh Y,Kuratsu J,Takeshima H,et al.Expression of osteopontin in human glioma.Its correlation with the malignancy.Lab Invest,1995,72(1):55-63.
74. Chambers AF,Wilson SM,Kerkvliet N,et al.Osteopontin expression in lung cancer.Lung Cancer,1996,15(3):311-323.
75. Patarca R,Saavedra RA,Cantor H.Molecular and cellular basis of genetic resistance to bacterial infection:the role of theearly T-lymphocyte activation-1/osteopontin gene .Crit RevImmunol,1993,13(3-4):225-246.
76. Weber GF,Ashkar S,Glimcher MJ,et al.Receptor-ligand intera-ction between CD44 and osteopontin (Eta-1).Science,1996,271(1):509-512.
77. Katagiri YU,Sleeman J,Fujii H,et al.CD44 variants but not CD44scooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine- glycine- aspartic acid , thereby stimulating cell motility and chemotaxis.Cancer Res,1999,59(1):219-226.
78. Brown LF,Papadopoulos-Sergiou A,Berse B,et al.Osteopontin expression and distribution in human carcinomas.Am Pathol,1994,145(3):610-623.
79. Rayall RL . Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.World Urol,1997,15(3):155-164.
80. Pichler R,Giachelli CM,Lombardi D,et al.Tubulointerstitial disease in glomerulonephritis.Potential role of osteopontin (uropontin).Am Pathol,1994,144(5):915-926.
81. Giachelli CM,Pichler R,Lombardi D,et al.Osteopontin expressionin angiotensin II-induced tubulointerstitial nephritis.Kidney Int,1994,45(2):515-524.
82. 常连胜,冯陶,郭应禄,等.结石病人尿骨桥蛋白测定的临床意义.中华泌尿外科杂志,2000,21(12):709-711.
83. 常连胜,冯陶, 郭应禄,等.维生素D 和维生素K 对结石大鼠肾脏骨桥蛋白mRNA 表达的影响.北京医科大学学报,1999,31(5) :429-431.
84. Majmudar G,Bole D,Goldstein SA,etal.Bone cell culture in a three-dimensional polymer bead stabilizes the differentiated phenotype and provides evidence that osteoblastic cells synthesize type III collagen and fibronectin.J Bone Miner Res,1991,6(8):869-881.
85. Weiss RE,Reddi AH.Synthesis and localization of fibronetin during collagenous matrix-mesenchymal cell interction and differentiation of cartilage and bone in vivo.Proc Natl Acad Sci USA,1980,77(4): 2074-2078.
86. 韩梅,温进坤,李相印,等.不同时相血管平滑肌细胞受促分裂原刺激后基因表达谱及迁移活性的比较.中国生物化学与分子生物学报,2000,16(6):809-813.
87. Liaw L,Almeida M,Hart CE,et al.Osteopontin promotes vascular cell adhesion and spreading and ischemotactic for smooth muscle cells in vitro.Circ Res,1994,74(2):214-224.
88. Kanzaki T,Shinomiya M,Ueda S,et al.Enhance arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDEF β receptor over pression of aortic media.Eur J Clin Invest,1994,24(6):3779.
89. 沈建箴,吕连煌.血浆纤连蛋白水平在急性白血病中的变化.中华医院感染学杂志,2000,10(4):279-280.
90. Weiss RE,Reddi AH.Appearance of fibronectin during the differentiation of cartilage,bone,and bone marrow.J Cell Biol,1981,88(3):630-636.
91. Couchouerl D,Escoffier C,Rohanizadeh R,etal.Effects of fibronectin on hydroxyapatite formation.J Inorg Biochem,1999,73(3):129-136.
92.Shimizu M,Minakuchi K,Kaji S,et al.Chondrocyte migration to fibronectin,type I collagen,and type II collagen.Cell Struct Funct,1997,22(3):309-315.
93. 陈希哲,杨连甲,杨维东.FN 对磷酸钙陶瓷表面修饰促进大鼠成骨细胞的贴附.牙体牙髓牙周病学杂志,2001,11(3):163-165.
94. 林红,牛膺筠,周占宇,等.眼睑恶性肿瘤组织中基底膜蛋白的分布和表达及临床意义.中华眼科杂志, 2003,39(3):167-171.
95. 吕雯,隋丽华,于丽波.上皮性卵巢癌纤连蛋白的表达及意义.哈尔滨医科大学学报,2000,34(2):98-99.
96. Kanzaki T,Shiina AR,Saito Y,et al.Transforming growth factor beta receptor and fibronect in expession in aortic smooth muscle cells in diabetic rats.Diabetologia,1997,40:383-391.
97. 郑丽丽,王建功,蒋晓钦,等.氯沙坦对大鼠血管成形术后转化生长因子β受体表达的影响.郑州大学学报(医学版),2002,37(1):45-47.
98. 谢怡敏,岳利民,何亚平,等.整合素系统对人精子顶体反应的作用.四川生理科学杂志,2003,25(1):29-32.
99. Liaw L,Skinner MP,Raines EW,et al.The adhesive and migratory effects of osteopontic are mediad via distinct cell surface integrins.J Clin Invest,1995,95(2):713-724.
100.刘智敏,韩梅,温进坤.细胞外基质促血管平滑肌细胞迁移及β3 整合素和粘着斑激酶表达.中国病理生理杂志,2003,19(2):163-166.
101.Hynes RO.Interin:versatility,modulation and signaling in cell adhesion.Cell,1992,69(1):11-25.
102.Sebag J,Balazs EA.Morphology and ultrastructure of human vitreous fibers.Invest Ophthalmol Vis Sci,1989,30;1867-1871.
103.Termine JD,Kleinman HK,Whitson SW,et al.Osteonectin,a bone-specific protein linking mineral to collagen.Cell,1981,26:99-105.
104.Sasaki T,Hohenester E,Gohring W,et al.Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.EMBO J,1998,17:1625-1634.
105.Bassuk JA,Birkebak T,Rothmier JD,et al.Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation.Exp Eye Res,1999,68(3):321-331.
106.Mishima H,Hibino T,Hara H,et al.SPARC from corneal epithelial cells modulates collagen contraction by keratocytes.Invest Ophthslmol Vis Sci,1998,39(13):2547-2553.
107. Kim SY,Ondhia N,Vidgen D,et al.Spatiotemporal distribution of SPARC/osteonectin in developing and mature chicken retina.Exp Eye Res,1997,65(5):681-689.
108.Funk SE,Sage EH.Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.J Cell Physiol,1993,154:53-63.
109. Motamed K.SPARC(osteonectin/BM-40).Int J Biochem Cell Biol,1999,31(12):1363-1366.
110. Chandrasekhar S,Harvey AK,Johnson MG,et a1.0steonectin/SPARCis a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors.Biochim Biophys Acta,1994,1221(1):7-14.
111.Gooden MD,Vernon RB,Bassuk JA,et a1.Cell cycle-dependent nuclear location of the matricellular protein SPARC :association with the nuclear matrix.J Cell Biochem,1999,74:152-167.
112.Pichler RH,Hugo C,Shankland ST,et al.SPARC is expressed in renal interstitial fibrosis and in renal vascular injury.Kidney Int,1996,50:1978-1989.
113.Schoenvaelder SM,Burridge K.Bidirectional signaling between the cytoskeleton integrins.Curr 0pin Cell Biol,1999,11:247-286.
114. AdamS JC.Stimlation of fascin spikes by thrombospondin-1 is mediated by the GTP asesrac and cdc42.J Cell Biol,2000,150:807-822.
115.Wenk MB,Midwood KS,Schwrazbauer JE.Tenascin-C suppresses Rho activation.J Cell Boil,2000,150:913-919.
116.Soderling JA,Reed MJ,Corsa A,et al.Cloning and expression of murine SC1,a gene product homologous to SPARC.J Histochem,1997,45 (60):823-835.
117.Rosenblatt S,Bassuk JA,Alpers CE,et al.Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins:characterization of the binding of vitronectin to osteonectin (BM40, SPARC).Biochem,1997,324: 311-319.
118. Ledda F,Bravo AI,Adria S,et al.The expression of the secretedprotein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.J Inv Dermatol,1997,108: 210-214.
119.Brekken RA,Sage EH.SPARC,a matricellular protein:at the crossroads of cell-matrix communication.Matrix Biol,2001,19(8):816-827.
120.Motamed K,Sage EH.SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphory-lation-dependent pathway.J Cell Biochem,1998,70:543-552.
121.Raines EW,Lane TF,Iruela-Arispe ML,et a1.The extracellular glycoprotein SPARC interacts with platelet-derived growth factor(PDGF)-AB and-BB and inhibits the binding of PDGF to its receptors.Proc Natl Acad Sci USA,1992,89:1281-1285.
122.Hasselaar P.SPARC antagonizes the effect of bFGF on the migration of bovine aortic endothelial cells.J Cell Biochem,1992,49:272-283.
123.Kelm RJ,Mann KG.The collagen binding Specificity of bone and platelet osteonectin is related to differences in glycosylation.J Biol Chem,1991,266:9632-9639.
124.Schoenvaelder SM,Burridge K.Bidirectional signaling between the cytoskeleton integrins.Curr 0pin Cell Biol,1999,11:247-286.
125.Yan Q,Sage EH.SPARC,a matricellular glycoprotein with important biological functions.J Histochem Cytochem,1999,47(12):1495-1506.
126.Schultz C,Lemke N,Ge S,et a1.Secreted protein acidic andrich in cysteine promotes g1ioma invasion and delays tumor growth in vivo.Cancer Res,2002,62 (21):6270-6277.
127.Francki A.SPARC and the kidney glomerulus:matricellular proteins exhibit diverse functions under normal and pathological conditions.Trends Cardiovasc Med,2001,11 (1):32-37.
128.Alpers CE.Localization of SPARC in developing,mature and chronically injured human allograft kidneys . Kidney international,2002,62:2073-2086.
129.Porte H,Tribolet JP,Kotelevets L,et al.Overexpression of stromelysin-3,BM-40/SPARC,and MET genes in human esophageal carcinoma:implications for prognosis.Clin Cancer Res,1998,4:1375-1382.
130.Ledda F,Bravo AI,Adria S,et al.The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.J Inv Dermatol,1997,108:210-214.
131.Rempel SA,Ge S,Gurierrez JA,et al.Increased SPARC expression promotes U87 glioblastoma invasion in vitro.Clin Cancer Res,1999,5:237-241.
132.Mok SC,Chan WY,Wang KK,et al.SPARC,an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.Oncogene,1996,12:1895-1901.
133.Gilles C,Bassuk JA,Pulyaeva H,et al.SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.Cancer Rcs,1998,58:5529-5536.
134.Latvala T,Puolakkainen P,Vesaluoma M,et al.Distribution ofSPARC prote in (osteonectin) in normal and wounded feline cornea.Exp Eye Res,1996,63(5):579-584.
135.Goldblum SE,Ding X,Funk SE.SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.Proc Natl Acad Sci,1994,91(8):3448-3352.
136.Sage EH,Bassuk JA,Yost JC,et al.Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.J Cell Biochem,1995,57(1):127-140.
137.Ishizaki M,Wskamatsu K,Matsunami T,et al.Dynamics of the expression of cytoskeleton components and adherens molecules by fibroblastic cells in alkali-burned and lacerated corneas.Exp Eye Res,1994,59(5):537-549.
138.Guidry C,Mcfarland RJ,Morris R,et al.Collagen gel contraction by cells associated with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci,1992,33(8):2429-2435
139. Yan Q,Sage EH.SPARC,a matricellular g1ycoprotein with imponant biological functions.J Histochem Cytochem,1999,47(12):1495-1506.
140. Yan Q,Clark H,Wight TN.Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice.J Cell Sci,2002,115 (Ptl3):2747-2756.
141. Hiscott P,Hagan S,Heathcote L,et a1.Pathobiology of epiretinal and subretinal membranes:possible roles for the matricellular proteins thrombospondin 1 and osteonectin(SPARC).Eye,2002,16(4):393-403.
142.Kantorow M,Huang Q,Yang XJ,et a1.Increased expression ofosteonectin/SPARC mRNA and protein in age-related human cataracts and spatial expression in the normal human 1ens.Mol Vis,2000,6:24-29.
143. Delarco JE,Todaro GJ.Growth factors from murine sarcoma virus transformed cells.Proc Natl Acad Sci USA,1978,75(8):4001-4009.
144. Blobe GC,Schiemann WP,Lodish HF.Role of transforming growth factor β in human disease.New Eng J Med,2000,342:1350-1358.
145. Crawford SE,Stellmach V,Murphy-Ullrich JE,et al.Thrombo spondinl is a major activator of TGF beta1 in vivo.Cell,1998,93(7):1159-1170.
146. Massague J.TGF betas ignaling:receptors,transducers,and Mad proteins.Cell,1996,85(7):947-950.
147. Pfeidchifter J,Mundy GR.Modulation of type beta transforming growth factor activity in bone culturea by osteptropic hormones.Proc Natl Acad Sci USA,1987,84(7):2024-2028.
148. Masagu J.TGFβ ignal transduction.Annu Rev Biochem,1998,67:753-791.
149. Derynck R,Feng XH.TGFβ Receptors ignaling.Biochim Biophys Acta,1997,1333:105-150.
150. Zhou S,Zilberman Y,Wassermann K,etal.Estrogen modulates estrogen receptor alpha and beta expression , osteogenic activity,and apoptosis in mesenchymal stem cells(MSCs)of osteoporotic mice .J Cell Biochem Suppl,2001,(Suppl36) :144-155.
151. Cao J,Gynons AI,Bartold PM.Expression of TGF-β1in the developing periodontium od rat.J Dent Res,1998,77(9):1708-1711.
152. Ueta C,Iwamoto M,Kanatani N,etal.Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes.J Cell Biol,2001,153(1):87-100.
153. 薛延.影响骨形成和骨吸收的有关因子.见:刘忠厚,主编.骨质疏松症.第1 版.北京:化学工业出版社;1992:121-139.
154. Sasse T,Becker P.TGF-β1 mRNA expression and proliferation of human osteoblastic cells in nonosteporotic women under influence of TGF-β1 and IGF-1.Calcified Tissue Int,1998, 62:140-147.
155. Gazit D,Zilberman Y,Ebner R,etal.Bone loss (osteopehia) in old male mice results from diminished activity and availability of TGF-beta.J Cell Biochem,1998,70:478-488.
156. Mehrara BJ,Saadeh PB,Steinbrech DS,etal.Adenovirus-mediated gene theraphy of osteoblasrs in vitro and in vivo.J Bone Miner Res,1999,14(8):1290-1301.
157. Takai H,Kanematsu M,Yano k,etal.Transforming growth factor beta stimulates the production of osteoprote gerin/osteoclasto-genesis inhibitory factor by bone marrow stromal cells.J Bio Chem,1998,273:27091-27096.
158. Bryant HU,Dere UH,SERMs.Multiple pathway for ER responses.Proc Soc Exp Binl Mes,1998,217(1):45-51.
159. Bord S,Beavan S,Ireland D,etal.Mechanisms by which high –dose estrogen therapy produces anabolic sketeral effects in postmenopausal woman : role of locally produced growth factor.Bone,2001,29(3):216-222.
160.Kim CH,Kim YH,Kim YK,etal.IL-beta induces and TGF-beta reduces vitamin D3-induced bone resorption in mouse calvaial bonecells.Immunol Invest,2003,32(3):171-186.
161. Bertoldo F,D’Agruma L,Furlan F,etal.Transforming growth factor beta1 gene polymorphism,bone turnover,and bone mass in Italian postmonopsusal women.J Bone Miner Res,2000,15:634-639.
162. Lind M.Growth factor stimulation of bone healing.Effects on osteoblasts,osteomies,and implants fixation.Acta Orthop Scand Suppl,1998,283:2-37.
163. Wu LL,Cox A,Roe CJ,et al.Transforming growth factor betal and Renal injury following subtotal nephrectomy in the rat:role of the Renin-angiotensin system.Kidney Int,1997,51:1553-1567.
164. 刘凯,钱云良,范志宏.转化生长因子β与组织创伤修复综述.中国修复重建外科杂志,1999,13(5):283-286.
165. Ziyadeh FN.Mediators of diabetic renal disease:the case for TGF-β as the major mediator.J Am Soc Nephrol,2004,15:55-57.
166. Pankewycz OG,Miao L,Isaacs R,etal.Increase ernal tubular expression of transforming growth factor betain human allografts correlates with cyclosporine toxicity.Kidny Int,1996,50(5):1634-1640.
167. Waiser J,Dell K,Bohler T,etal.Cylcosporine A up regulaters the expression of TGF-β1 and its receptors type Ⅰand typeⅡin rat mesangial cells.Nephrol Dial Transplant,2002,17(9):1568-1577.
168. Paillard F.Immunosuppression mediated by tumor cells:a challenge for immunotherapeutic approaches.Hum Gene Ther,2000,11(5),657-658.
169. 齐同谦.转化生长因子β与肿瘤关系研究进展.《国外医学》免疫学分册,2002,25(1):20-22.
170. 程继义,蒋绍博,王杰.转化生长因子β1 及β3 在前列腺癌中的表达及其意义.中华泌尿外科杂志,1999,20(7):422-424.
171. Srivastava RN,Gill DS,Moudgil A,etal.Normal ionized calcium,parathyroid hypersecretion,and elevated osteocalcin in a family with fluorosis.Metabolism,1989,38:120-124.
172. 缪庆,徐茗,刘秉慈,等.过量氟对大鼠体内、外Ⅰ型胶原蛋白的影响.卫生研究,2002,31(3):145-147.
173. Reed BY,Zerwekh JE,Antich PP,et al.Fluoride-stimulated [3H] thymidine uptake in a human osteoblastic osteosatrcoma cell line is dependent on transforming growth factor beta.J Bone Miner Res,1993,8(1):19-25.
174. Globus RK,Doty SB,Lull JC,et al.Fibronectin is a survial factor for differentiated osteoblasts.J Cell Sci1998,111:1385-1393.
175. Young MF,Kerr JM,Ibaraki K,et al.Structure,expression and regulation of the major noncollagenous matrix proteins in bone.Clin Orthop,1992,281:275-294.
176. Delany AM,Amling M,Priemel M,et al.Osteopenia and decreased bone formatin in osteonectin-deficient mice.J Clin Invest,2000,105(7):915-923.
177. Machwate M,Zerath E,Holy X,et al.Systemic administration of transforming growth factor-b2 prevents the impaired bone formation and osteopenia induced by unloading in rats.J Clin Invest,1995,96:1245-1253.
178. Reed BY,Zerwekh JE,Antich PP,et al.Fluoride-stimulated [3H] thymidine uptake in a human osteoblastic osteosatrcoma cellline is dependent on transforming growth factor beta.J Bone Miner Res,1993,8(1):19-25.